GSK 626616 is a novel, potent, and orally bioavailable YAK3/DYRK3 kinase inhibitor with IC50 of 0.7 nM for DYRK3. It is a chemoprotective agent for the potential treatment of chemotherapy-induced anaemia.

纯度：≥98%

CAS：1025821-33-3